Sagimet Biosciences Inc.
SGMT | NASDAQ
$10.80
-$0.29 (-2.61%)
At close: Sep 21, 2026, 4:00 PM ET
$10.95
+$0.15 (+1.39%)
Pre-market:
Sep 22, 2026, 8:55 AM ET
Fiscal Year Period Ending | FY 2025 Dec 30, 2025 | FY 2024 Dec 30, 2024 | FY 2023 Dec 30, 2023 | FY 2022 Dec 30, 2022 | FY 2021 Dec 30, 2021 | FY 2020 Dec 30, 2020 |
|---|---|---|---|---|---|---|
Revenue | n/a | n/a | 2M | n/a | n/a | n/a |
Cost of Revenue | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit | n/a | n/a | 2M | n/a | n/a | n/a |
Operating Income | -56.89M | -54.45M | -30.74M | -31.06M | -23.72M | -11.4M |
Interest Income | 5.85M | 8.89M | 2.86M | 553K | 26K | 30K |
Pretax Income | -51.04M | -45.57M | -27.88M | -30.5M | -24.44M | -11.37M |
Net Income | -51.04M | -45.57M | -27.88M | -30.5M | -24.44M | -11.37M |
Selling & General & Admin | 17.84M | 16.01M | 12.96M | 6.14M | 4.38M | 3.22M |
Research & Development | 39.05M | 38.44M | 19.78M | 24.92M | 19.34M | 8.18M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 56.89M | 54.45M | 32.74M | 31.06M | 23.72M | 11.4M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 56.89M | 54.45M | 32.74M | 31.06M | 23.72M | 11.4M |
Income Tax Expense | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 32.35M | 31.35M | 18.19M | 22.17M | 22.17M | 22.17M |
Shares Outstanding (Diluted) | 32.35M | 31.35M | 18.19M | 22.17M | 22.17M | 22.17M |
EPS (Basic) | -1.58 | -1.45 | -1.53 | -1.38 | -1.10 | -0.51 |
EPS (Diluted) | -1.58 | -1.45 | -1.53 | -1.38 | -1.10 | -0.51 |
EBITDA | -51.04M | -45.57M | -27.88M | -30.37M | -24.44M | -11.4M |
EBIT | -51.04M | -45.57M | -27.88M | -30.5M | -24.44M | -11.4M |
Depreciation & Amortization | n/a | n/a | n/a | 130K | n/a | 1K |
Add to Watchlist
Select watchlists to add or remove SGMT